Stock Code: 002365 Stock Abbreviation: Yong'an Pharmaceutical Announcement No.: 2026-18 Qianjiang Yong'an Pharmaceutical Co., Ltd. Announcement on the 2025 Profit Distribution Plan
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and that there are no false records, misleading statements, or material omissions.
I. Deliberation Procedures On April 15, 2026, Qianjiang Yong'an Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") held the 14th meeting of the 7th Board of Directors, which deliberated and approved the "2025 Profit Distribution Plan." This proposal still needs to be submitted to the Company's 2025 Shareholders' Meeting for deliberation and approval before it can be implemented.
II. Basic Information of the Profit Distribution Plan According to the audited 2025 financial report by Lixin Certified Public Accountants (Special General Partnership), the net profit attributable to shareholders of listed companies in the consolidated statements for 2025 was RMB 22,493,429.92, and the distributable profit for shareholders in the consolidated statements was RMB 830,807,637.84. In 2025, the net profit realized by the Company (parent company) was RMB 31,777,661.16, and the distributable profit for shareholders of the parent company was RMB 890,251,718.08. Based on the principle of the lower of the distributable profit in the consolidated statements and the parent company statements, the distributable profit for shareholders as of December 31, 2025, was RMB 830,807,637.84.